Evidence map›Paper›PMID 36329819›Full record

ArticleFrontiers in cellular and infection microbiology2022

Prevalence and distribution of ampc beta-lactamase producing

Camille-Ann Thoms Rodriguez, Felecia Dawson, Jenene Cameron, Christine Seah, Marvin Reid, Roberto G Melano, Maxine Gossell-Williams

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Novel Variant of New Delhi Metallo-Beta-Lactamase (Antibiotics (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Camille-Ann Thoms RodriguezDepartment of Microbiology, The University of the West Indies, Kingston, Jamaica.
Felecia DawsonDepartment of Basic Medical Sciences, The University of the West Indies, Kingston, Jamaica.
Jenene CameronDepartment of Microbiology, The University Hospital of the West Indies, Kingston, Jamaica.
Christine SeahDepartment of Clinical Lab and Microbiology Sciences, Public Health Ontario Laboratory, Toronto, ON, Canada.
Marvin ReidCaribbean Institute for Health Research, The University of the West Indies, Kingston, Kingston, Jamaica.
Roberto G MelanoDepartment of Clinical Lab and Microbiology Sciences, Public Health Ontario Laboratory, Toronto, ON, Canada.
Maxine Gossell-WilliamsDepartment of Basic Medical Sciences, The University of the West Indies, Kingston, Jamaica.
University of the West Indies · JMPublic Health Ontario · CAUniversity Hospital of the West Indies · JM

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The aim of this study was to investigate the prevalence and distribution of AmpC beta-lactamases (BLs) in uropathogens ( Method: De-duplicated consecutive urine samples, collected from January to March 2020 at the UHWI, were analyzed. Screening and phenotypic confirmatory tests were conducted using resistance to cefoxitin and the Disc Approximation Test (DAT) respectively, for isolates of interest. Multiplex PCR was performed on cefoxitin resistant (CR) isolates for the detection of Results: Sixty-four Gram negative isolates were obtained from 61 patients (55% female), aged 18 months to 88 years old. At least 35% (26) had complicated urinary tract infections. Only 7 out of 64 isolates were Conclusion: AmpC BL prevalence among

Indexed as

Escherichia coliKlebsiella pneumoniaeAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCefoxitinFemaleHumansMaleMicrobial Sensitivity TestsPrevalenceTertiary Care CentersAmpC beta-lactamasesAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCefoxitinAmpCantibiotic resistancebeta-lactamasemdrouropathogens

Identifiers

PMID36329819
PMCPMC9623010
OpenAlexW4306672601

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.